Skip to main content
Clinical Trials/NCT03170505
NCT03170505
Completed
Not Applicable

Using of Acellular Dermal Matrix in Cleft Palatal Fistula and Compare With Use of Conchal Cartolage

Isfahan University of Medical Sciences0 sites60 target enrollmentMay 27, 2015
ConditionsCleft Palate

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cleft Palate
Sponsor
Isfahan University of Medical Sciences
Enrollment
60
Primary Endpoint
Fistula formation
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The fact that still exist is which method for repairing of secondary cleft palatal fistula is the best. This study will have shown whether using of Acellular dermal Matrix decreased the fistula formation versus using Conchal Cartilage during secondary fistula. Among studies that published, they have not consensus for using acellular dermal matrix. Most of the questions are about cost effectiveness, time that surgery and rehabilitation need and patient risk ( risk of transmission disease from other human tissue )

Detailed Description

Observational study composed of a prospective cohort group receiving ADM compared to a retrospective historical cohort group with Conchal Cartilage. Primary objectives: The primary objective of this study is to determine whether ADM would lower the incidence of palatal fistula in patients undergoing secondary cleft palate fistula repair. Secondary objectives: 1. hypo nasality speech after surgery 2. Improvement Speech Score

Registry
clinicaltrials.gov
Start Date
May 27, 2015
End Date
May 27, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Meisam AbdarEsfahani

Using of Acellular Dermal Matrix in cleft palatal fistula and compare with Use of Conchal Cartolage

Isfahan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed as having cleft palate fistula, with ADM will be included in this study.

Exclusion Criteria

  • Selection will be based on the patient's willingness to allow to participate in the study.
  • Patients with diagnosed craniofacial syndromes will be excluded from the study.
  • Children with known wound healing defects, will be excluded from the study.

Outcomes

Primary Outcomes

Fistula formation

Time Frame: Within 2 year of surgery

Similar Trials